Search - tctmd.com

Displaying 81 - 100 of 390

Sort: Relevancy | Date

Presentation TCT 2023

TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque)

Presenter: Sanghoon Shin

October 25, 2023

Presentation TCT 2023

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

Presenter: Retesh Bajaj

October 25, 2023

Presentation TCT 2023

TCT 617: Plaque Stabilization and Regression: Another Significant Benefit of DynamX Bioadaptor

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

TCT 177: Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients with Chronic Coronary Syndrome

Presenter: Tetsuya Yamamoto

October 25, 2023

Presentation TCT 2023

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Presenter: David del Val

October 25, 2023

Presentation TCT 2023

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Presenter: David Erlinge

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

Presenter: Takashi Kubo

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Detection: The Time Has Passed

Presenter: Daniele Giacoppo

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Detection: We Must Keep Looking

Presenter: Bjorn Redfors

October 24, 2023

Presentation TCT 2023

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

Presenter: Gary Mintz

October 24, 2023

Presentation TCT 2023

What Is a Vulnerable Plaque? Lessons From Histopathology

Presenter: Aloke Finn

October 24, 2023

Presentation TCT 2023

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Presenter: Bimmer Claessen

October 24, 2023

News Daily News

Small Study Hints at Mechanism for COVID-Related MI and Stroke

L.A. McKeown

October 02, 2023

News Daily News

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

Caitlin E. Cox

September 18, 2023

News Conference News ESC 2023

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

Michael O'Riordan

August 26, 2023

News Daily News

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

Todd Neale

August 01, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Featured Fellow

Priya Kothapalli, MD

Yael L. Maxwell

January 03, 2023

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

Advertisement

TCT 645: Changes in Plaque Lipid Content After 1 year Intensive Versus Standard Statin Therapy : CITRUS study (Serial near-infrared spectroscopy assessment of change in coronary atherosclerotic plaque)

TCT 635: Performance of Near-Infrared Spectroscopy-Intravascular Ultrasound and Optical Coherence Tomography for Coronary Artery Plaque Structural Stress Analysis: Validation Against Histology

TCT 617: Plaque Stabilization and Regression: Another Significant Benefit of DynamX Bioadaptor

TCT 177: Impact of Pericoronary Adipose Tissue Attenuation on Periprocedural Myocardial Injury in Patients with Chronic Coronary Syndrome

TCT 140: Combined Coexistence of Multiple Vulnerable Plaque Features is Associated with Incremental Rates of Adverse Events in Patients with Diabetes Mellitus. New Insights From the COMBINE OCT-FFR trial

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

Vulnerable Plaque Detection: The Time Has Passed

Vulnerable Plaque Detection: We Must Keep Looking

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

What Is a Vulnerable Plaque? Lessons From Histopathology

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Small Study Hints at Mechanism for COVID-Related MI and Stroke

High-risk Plaques in Nonculprit Lesions Tied to Worse Post-MI Outcomes

FIRE: Complete Revascularization Best Even for Elderly Patients With MI

High-Sensitivity Troponin Assays May Stratify Risk in Chronic CAD

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Priya Kothapalli, MD

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content